2 July 2026 | 12:30–17:30 CEST | Amsterdam, the Netherlands | Stakeholder meeting
An European Medicines Agency (EMA) Industry Stakeholder Platform on Research and Development Support, focused on evidence generation across the medicines lifecycle and regulatory support for research and development activities.
Topics covering scientific advice, model-informed drug development, the PRIME scheme, qualification of novel methodologies, paediatric development, real-world data and evidence, and implementation of the new EU pharmaceutical legislation. The agenda also includes initial considerations on the new concept of a regulatory sandbox, providing a particularly strong link to BRIDGE’s work.